COVID-19 vaccines: where we stand and challenges ahead

In the eleven months elapsed since the identification of the SARS-CoV-2 virus and its genome, an exceptional effort by the scientific community has led to the development of over 300 vaccine projects. Over 40 are now undergoing clinical evaluation, ten of these are in Phase III clinical trials, thre...

Full description

Saved in:

Bibliographic Details
Published in:	Cell death and differentiation Vol. 28; no. 2; pp. 626 - 639
Main Authors:	Forni, Guido, Mantovani, Alberto
Format:	Journal Article
Language:	English
Published:	England Nature Publishing Group 01.02.2021
Subjects:	Bacillus Calmette-Guerin vaccine BCG Clinical trials COVID-19 COVID-19 - epidemiology COVID-19 - immunology COVID-19 - prevention & control COVID-19 vaccines COVID-19 Vaccines - immunology COVID-19 Vaccines - therapeutic use Genomes Humans Innate immunity Pandemics Pandemics - prevention & control SARS-CoV-2 - immunology Severe acute respiratory syndrome coronavirus 2 Vaccines
ISSN:	1350-9047, 1476-5403, 1476-5403
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!